Medicared For All Logo

Lynne Bui MD in Los Gatos, California

Home California Los Gatos

Lynne Bui MD has Hematology/oncology as her primary medical specialty. Their primary office is: 14651 S Bascom Ave in Los Gatos, California. There is an additional office location, for a total of two, for Lynne Bui MD that can be viewed further down. They attended University Of California, Geffen School Of Medicine and graduated in 1997 (around 27 years of experience). They are listed as doing telehealth appointments.


Lynne Ai Bui MD Office Phone and Directions

Lynne Bui MD
14651 S Bascom Ave
Los Gatos, California 95032
408-384-9284


Patient Ratings
Please rate your experience with Lynne Bui MD below to help others make a more informed decision. Thanks!
Current Rating: Loading...

Phone: 408-384-9284


Enter a starting address:


Healthcare Info for Lynne Bui MD

Additional Medical Specialties Include:
INTERNAL MEDICINE

Medical School: University Of California, Geffen School Of Medicine
Graduation Year: 1997
The Primary Medical Specialty for Lynne Bui MD is listed as: Hematology/oncology
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 27
PAC (PECOS ID)#: 3577585413
NPI #: 1114169323
NPI Created On: 04/02/2009
NPI Last Updated Listed as: 08/03/2022
Primary Taxonomy Code: 207R00000X
License Number:
A66600
Listed Gender: Female

Insurance, Services, Charges


Forms of insurance accepted by include, but are not limited to:

  • Humana
  • Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Vietnamese, French, Chinese.


Services and Procedures include:

  1. Insertion of needle or catheter into an artery of arm or leg
  2. Insertion of needle into vein for collection of blood sample
  3. Hydration infusion into a vein 31 minutes to 1 hour
  4. Hydration infusion into a vein
  5. Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour
  6. Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour
  7. Infusion into a vein for therapy, prevention, or diagnosis, concurrent with another infusion
  8. Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
  9. Infusion of chemotherapy into a vein up to 1 hour
  10. Infusion of chemotherapy into a vein
  11. Therapeutic removal of whole blood to correct blood level imbalance
  12. New patient office or other outpatient visit, typically 60 minutes
  13. Established patient office or other outpatient visit, typically 15 minutes
  14. Established patient office or other outpatient, visit typically 25 minutes
  15. Established patient office or other outpatient, visit typically 40 minutes
  16. Subsequent hospital inpatient care, typically 35 minutes per day
  17. Injection, epoetin alfa, (for non-esrd use), 1000 units
  18. Injection, denosumab, 1 mg
  19. Injection, dexamethasone sodium phosphate, 1 mg
  20. Injection, diphenhydramine hcl, up to 50 mg

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.


Payments Total: $18

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787824753

Being Disputed:: No

Product Related: No


Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787824765

Being Disputed:: No

Product Related: No


Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787824775

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: BALVERSA

Open Associated Drug #1: 59676-030-56

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: ERLEADA

Associated Drug #2: 59676-600-12


Payments Total: $23

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787824785

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: BALVERSA

Associated Drug #2: 59676-030-56


Payments Total: $25

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787824797

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: BALVERSA

Associated Drug #2: 59676-030-56


Payments Total: $24

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787824803

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: BALVERSA

Associated Drug #2: 59676-030-56


Payments Total: $25

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787824815

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: DARZALEX

Associated Drug #2: 57894-502-05


Payments Total: $29

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787824827

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: DARZALEX

Associated Drug #2: 57894-502-05


Payments Total: $29

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 818584839

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: VERZENIO

Open Associated Drug #1: 0002-6216-54

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: RETEVMO

Associated Drug #2: 0002-2980-60


Payments Total: $32

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 818630171

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: VERZENIO

Open Associated Drug #1: 0002-6216-54

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: RETEVMO

Associated Drug #2: 0002-2980-60


Additional Office Locations

1.
14911 National Ave
Los Gatos, CA 95032
Suite 1
Group Members: 0

Phone: 408-384-9284

Enter a starting address:


Hematology/oncology Professionals in Los Gatos

815 Pollard Rd
Los-gatos, CA
Silicon Valley Medical Development Llc

815 Pollard Rd
Los-gatos, CA
Silicon Valley Medical Development Llc

815 Pollard Rd
Los-gatos, CA
Silicon Valley Medical Development Llc

Providers in the same medical group

1.Jon Aagaard

2001 N Gary Ave
Wheaton Il 60187-3055
Family Practice

2.Matthew Aaker

8055 W Ave
Castle Hills Tx 78213-1842
Optometry

3.Justin Aaker

3613 Williams Dr
Georgetown Tx 78628-1373
Ophthalmology

4.Mohammad Aalai

7005 35th Ave
Jackson Heights Ny 11372-3970
Physical Medicine And Rehabilitation

5.Carol Aalbers Cp

4560 S Carson St
Carson City Nv 89701-6915
Clinical Psychologist

6.Hina Aamir

602 S Atwood Rd
Bel Air Md 21014-4323
Psychiatry